These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 32202252)
1. Haploidentical bone marrow transplant with posttransplant cyclophosphamide for sickle cell disease: An update. Patel DA; Akinsete AM; de la Fuente J; Kassim AA Hematol Oncol Stem Cell Ther; 2020 Jun; 13(2):91-97. PubMed ID: 32202252 [TBL] [Abstract][Full Text] [Related]
2. Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide Plus Thiotepa Improves Donor Engraftment in Patients with Sickle Cell Anemia: Results of an International Learning Collaborative. de la Fuente J; Dhedin N; Koyama T; Bernaudin F; Kuentz M; Karnik L; Socié G; Culos KA; Brodsky RA; DeBaun MR; Kassim AA Biol Blood Marrow Transplant; 2019 Jun; 25(6):1197-1209. PubMed ID: 30500440 [TBL] [Abstract][Full Text] [Related]
3. An international learning collaborative phase 2 trial for haploidentical bone marrow transplant in sickle cell disease. Kassim AA; de la Fuente J; Nur E; Wilkerson KL; Alahmari AD; Seber A; Bonfim C; Simões BP; Alzahrani M; Eckrich MJ; Horn B; Hanna R; Dhedin N; Rangarajan HG; Gouveia RV; Almohareb F; Aljurf M; Essa M; Alahmari B; Gatwood K; Connelly JA; Dovern E; Rodeghier M; DeBaun MR Blood; 2024 Jun; 143(25):2654-2665. PubMed ID: 38493482 [TBL] [Abstract][Full Text] [Related]
4. HLA Haploidentical Stem Cell Transplant with Pretransplant Immunosuppression for Patients with Sickle Cell Disease. Pawlowska AB; Cheng JC; Karras NA; Sun W; Wang LD; Bell AD; Gutierrez L; Rosenthal J Biol Blood Marrow Transplant; 2018 Jan; 24(1):185-189. PubMed ID: 28939451 [TBL] [Abstract][Full Text] [Related]
5. Haploidentical Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide and Peripheral Blood Stem Cell Grafts in Older Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome. Slade M; DiPersio JF; Westervelt P; Vij R; Schroeder MA; Romee R Biol Blood Marrow Transplant; 2017 Oct; 23(10):1736-1743. PubMed ID: 28688919 [TBL] [Abstract][Full Text] [Related]
6. The range of haploidentical transplant protocols in sickle cell disease: all haplos are not created equally. Kassim AA; DeBaun MR Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):532-541. PubMed ID: 38066894 [TBL] [Abstract][Full Text] [Related]
7. Haploidentical hematopoietic stem cell transplant for patients with sickle cell disease using thiotepa, fludarabine, thymoglobulin, low dose cyclophosphamide, 200 cGy tbi and post transplant cyclophosphamide. Frangoul H; Evans M; Isbell J; Bruce K; Domm J Bone Marrow Transplant; 2018 May; 53(5):647-650. PubMed ID: 29339800 [No Abstract] [Full Text] [Related]
8. Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission. Rashidi A; Hamadani M; Zhang MJ; Wang HL; Abdel-Azim H; Aljurf M; Assal A; Bajel A; Bashey A; Battiwalla M; Beitinjaneh AM; Bejanyan N; Bhatt VR; Bolaños-Meade J; Byrne M; Cahn JY; Cairo M; Ciurea S; Copelan E; Cutler C; Daly A; Diaz MA; Farhadfar N; Gale RP; Ganguly S; Grunwald MR; Hahn T; Hashmi S; Hildebrandt GC; Holland HK; Hossain N; Kanakry CG; Kharfan-Dabaja MA; Khera N; Koc Y; Lazarus HM; Lee JW; Maertens J; Martino R; McGuirk J; Munker R; Murthy HS; Nakamura R; Nathan S; Nishihori T; Palmisiano N; Patel S; Pidala J; Olin R; Olsson RF; Oran B; Ringden O; Rizzieri D; Rowe J; Savoie ML; Schultz KR; Seo S; Shaffer BC; Singh A; Solh M; Stockerl-Goldstein K; Verdonck LF; Wagner J; Waller EK; De Lima M; Sandmaier BM; Litzow M; Weisdorf D; Romee R; Saber W Blood Adv; 2019 Jun; 3(12):1826-1836. PubMed ID: 31201170 [TBL] [Abstract][Full Text] [Related]
9. Haploidentical bone marrow transplantation with post transplant cyclophosphamide for patients with X-linked adrenoleukodystrophy: a suitable choice in an urgent situation. Fernandes JF; Bonfim C; Kerbauy FR; Rodrigues M; Esteves I; Silva NH; Azambuja AP; Mantovani LF; Kutner JM; Loth G; Kuwahara CC; Bueno C; Kondo AT; Ribeiro AAF; Kok F; Hamerschlak N Bone Marrow Transplant; 2018 Apr; 53(4):392-399. PubMed ID: 29330393 [TBL] [Abstract][Full Text] [Related]
10. HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease. Bolaños-Meade J; Fuchs EJ; Luznik L; Lanzkron SM; Gamper CJ; Jones RJ; Brodsky RA Blood; 2012 Nov; 120(22):4285-91. PubMed ID: 22955919 [TBL] [Abstract][Full Text] [Related]
11. Effect of increased dose of total body irradiation on graft failure associated with HLA-haploidentical transplantation in patients with severe haemoglobinopathies: a prospective clinical trial. Bolaños-Meade J; Cooke KR; Gamper CJ; Ali SA; Ambinder RF; Borrello IM; Fuchs EJ; Gladstone DE; Gocke CB; Huff CA; Luznik L; Swinnen LJ; Symons HJ; Terezakis SA; Wagner-Johnston N; Jones RJ; Brodsky RA Lancet Haematol; 2019 Apr; 6(4):e183-e193. PubMed ID: 30878319 [TBL] [Abstract][Full Text] [Related]
16. Bone marrow versus peripheral blood as a graft source for haploidentical donor transplantation in adults using post-transplant cyclophosphamide-A systematic review and meta-analysis. Yu X; Liu L; Xie Z; Dong C; Zhao L; Zhang J; Gu J; Zhu HH Crit Rev Oncol Hematol; 2019 Jan; 133():120-128. PubMed ID: 30661648 [TBL] [Abstract][Full Text] [Related]
17. Early viral reactivation despite excellent immune reconstitution following haploidentical Bone marrow transplant with post-transplant cytoxan for sickle cell disease. Patel DA; Dhedin N; Chen H; Karnik L; Gatwood K; Culos K; Mohan S; Engelhardt BG; Kitko C; Connelly J; Satyanarayana G; Jagasia M; De La Fuente J; Kassim A Transpl Infect Dis; 2020 Feb; 22(1):e13222. PubMed ID: 31782875 [TBL] [Abstract][Full Text] [Related]
18. Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease. Wiebking V; Hütker S; Schmid I; Immler S; Feuchtinger T; Albert MH Ann Hematol; 2017 Aug; 96(8):1373-1377. PubMed ID: 28573314 [TBL] [Abstract][Full Text] [Related]
19. Comparison of Outcomes after Peripheral Blood Haploidentical versus Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia: A Retrospective Single-Center Review. Rashidi A; DiPersio JF; Westervelt P; Vij R; Schroeder MA; Cashen AF; Fehniger TA; Romee R Biol Blood Marrow Transplant; 2016 Sep; 22(9):1696-1701. PubMed ID: 27223108 [TBL] [Abstract][Full Text] [Related]
20. Improvement in processing speed following haploidentical bone marrow transplant with posttransplant cytoxan in children and adolescents with sickle cell disease. Prussien KV; Patel DA; Wilkerson K; Armstrong B; Karnik L; de la Fuente J; Kassim AA Pediatr Blood Cancer; 2020 Jan; 67(1):e28001. PubMed ID: 31595633 [No Abstract] [Full Text] [Related] [Next] [New Search]